Financial Review: Ability (ABIL) & Imperva (IMPV)

Imperva (NASDAQ: IMPV) and Ability (NASDAQ:ABIL) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Earnings and Valuation

This table compares Imperva and Ability’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Imperva $321.72 million 4.91 $22.86 million $0.68 66.69
Ability $16.51 million 0.63 -$8.05 million N/A N/A

Imperva has higher revenue and earnings than Ability.


This table compares Imperva and Ability’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva 7.11% -3.28% -1.94%
Ability -364.52% -252.84% -50.65%

Insider & Institutional Ownership

2.1% of Ability shares are owned by institutional investors. 1.1% of Imperva shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Imperva and Ability, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 2 4 9 0 2.47
Ability 0 1 0 0 2.00

Imperva currently has a consensus target price of $52.58, indicating a potential upside of 15.95%. Ability has a consensus target price of $1.30, indicating a potential upside of 222.74%. Given Ability’s higher possible upside, analysts clearly believe Ability is more favorable than Imperva.

Volatility & Risk

Imperva has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Ability has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500.


Imperva beats Ability on 10 of the 12 factors compared between the two stocks.

About Imperva

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

About Ability

Ability Inc. is a holding company. The Company operates through its subsidiaries, Ability Computer & Software Industries Ltd. and Ability Security Systems Ltd., which provide interception, geolocation and cyber intelligence tools for security and intelligence agencies, military forces, law enforcement agencies and homeland security agencies around the world. The Company is engaged in off-air interception of voice, short message service (SMS), and data communication from both cellular and satellite communication networks, and deciphering solutions for both cellular and satellite communications. The Company’s product categories include Cellular Interception, Cellular Counter Interception, Satellite Interception, Geolocation, Cyber and Crime Prevention. Its Cellular Interception systems include Ultimate Interceptor (ULIN), IBIS, TouchDown, ACIS, AGIS-51 and 3G-Cat. Its Satellite Interception systems include IRIS, ATIS and SLIS.

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with's FREE daily email newsletter.

Leave a Reply